SOD1 and amyotrophic lateral sclerosis: Despite these challenges, recently reaffirmed US care guidelines do not address the offer of genetic testing13 (reaffirmed February 25, 2023), and European guidelines specify that ALS genetic testing should be offered only to patients with familial ALS or the SOD1 D90A phenotype.14